Antibodies, Monoclonal [CS] class drugs

31 results

  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen, Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
    Medication Details
    Drug Interactions

  • bavencio - avelumab injection, solution, concentrate

    (Avelumab)
    Emd Serono, Inc.
    Bavencio (avelumab) is a PD-L1 blocking antibody indicated for metastatic Merkel cell carcinoma (adults and patients 12+), locally advanced or metastatic urothelial carcinoma (maintenance after platinum chemotherapy or following progression on platinum chemotherapy), and advanced renal cell carcinoma (first-line, with axitinib).
    Medication Details
    Drug Interactions

  • darzalex - daratumumab injection, solution, concentrate

    (Daratumumab)
    Janssen Biotech, Inc.
    DARZALEX treats multiple myeloma in adults — used in newly diagnosed patients ineligible or eligible for stem cell transplant, and in relapsed/refractory cases after one or more prior therapies, as part of various combination regimens or as monotherapy.
    Medication Details
    Drug Interactions

  • darzalex faspro - daratumumab and hyaluronidase - fihj

    (Daratumumab And Hyaluronidase-Fihj (Human Recombinant))
    Janssen Biotech, Inc.
    DARZALEX FASPRO treats adult patients with multiple myeloma (newly diagnosed or relapsed/refractory, across various combination regimens), high-risk smoldering multiple myeloma, and newly diagnosed light chain (AL) amyloidosis. Not recommended for AL amyloidosis with NYHA Class IIIB/IV cardiac disease outside clinical trials.
    Medication Details
    Drug Interactions

  • dupixent - dupilumab injection, solution

    (Dupilumab)
    Sanofi-Aventis U.S. Llc
    Dupixent treats moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, COPD with eosinophilic phenotype, chronic spontaneous urticaria, bullous pemphigoid, and allergic fungal rhinosinusitis across adults and eligible pediatric patients.
    Medication Details
    Drug Interactions